Structural determinants of the hyperalgesic activity of myotoxic Lys49-phospholipase A2
Tóm tắt
Bothropstoxin-I (BthTx-I) is a Lys49-phospholipase A2 (Lys49-PLA2) from the venom of Bothrops jararacussu, which despite of the lack of catalytic activity induces myotoxicity, inflammation and pain. The C-terminal region of the Lys49-PLA2s is important for these effects; however, the amino acid residues that determine hyperalgesia and edema are unknown. The aim of this study was to characterize the structural determinants for the Lys49-PLA2-induced nociception and inflammation. Scanning alanine mutagenesis in the active-site and C-terminal regions of BthTx-I has been used to study the structural determinants of toxin activities. The R118A mutant was employed as this substitution decreases PLA2 myotoxicity. In addition, K115A and K116A mutants – which contribute to decrease cytotoxicity – and the K122A mutant – which decreases both myotoxicity and cytotoxicity – were also used. The H48Q mutant – which does not interfere with membrane damage or myotoxic activity – was used to evaluate if the PLA2 catalytic site is relevant for the non-catalytic PLA2-induced pain and inflammation. Wistar male rats received intraplantar injections with mutant PLA2. Subsequently, hyperalgesia and edema were evaluated by the paw pressure test and by a plethysmometer. Native and recombinant BthTx-I were used as controls. Native and recombinant BthTx-I induced hyperalgesia and edema, which peaked at 2 h. The R118A mutant did not induce nociception or edema. The mutations K115A and K116A abolished hyperalgesia without interfering with edema. Finally, the K122A mutant did not induce hyperalgesia and presented a decreased inflammatory response. The results obtained with the BthTx-I mutants suggest, for the first time, that there are distinct residues responsible for the hyperalgesia and edema induced by BthTx-I. In addition, we also showed that cytolytic activity is essential for the hyperalgesic effect but not for edematogenic activity, corroborating previous data showing that edema and hyperalgesia can occur in a non-dependent manner. Understanding the structure-activity relationship in BthTx-I has opened new possibilities to discover the target for PLA2-induced pain.
Tài liệu tham khảo
Dennis EA. Diversity of group types, regulation, and function of phospholipase A2. J Biol Chem. 1994;269(18):13057–60.
Valentin E, Lambeau G. Increasing molecular diversity of secreted phospholipases A2 and their receptors and binding proteins. Biochim Biophys Acta. 2000;1488(1–2):59–70.
Harris LK, Franson RC. [1-14C] oleate-labeled autoclaved yeast: a membranous substrate for measuring phospholipase A2 activity in vitro. Anal Biochem. 1991;193(2):191–6.
Dunn RD, Broady KW. Snake inhibitors of phospholipase A2 enzymes. Biochim Biophys Acta. 2001;1533(1):29–37.
Arni RK, Ward RJ. Phospholipase A2--a structural review. Toxicon. 1996;34(8):827–41.
Gutiérrez JM, Lomonte B. Phospholipase A2 myotoxins from Bothrops snake venoms. Toxicon. 1995;33(11):1405–24.
de Oliveira AH, Giglio JR, Andrião-Escarso SH, Ito AS, Ward RJ. A pH-induced dissociation of the dimeric form of a lysine 49-phospholipase A2 abolishes Ca2 + −independent membrane damaging activity. Biochemistry. 2001;40(23):6912–20.
Ownby CL. Selistre de Araujo HS, White SP, Fletcher JE. Lysine 49 phospholipase A2 proteins. Toxicon. 1999;37(3):411–45.
Soares AM, Guerra-Sá R, Borja-Oliveira CR, Rodrigues VM, Rodrigues-Simioni L, Rodrigues V, et al. Structural and functional characterization of BnSP-7, a Lys49 myotoxic phospholipase A2 homologue from Bothrops neuwiedi pauloensis venom. Arch Biochem Biophys. 2000;378(2):201–9.
Páramo L, Lomonte B, Pizarro-Cerdá J, Bengoechea JA, Gorvel JP, Moreno E. Bactericidal activity of Lys49 and Asp49 myotoxic phospholipases A2 from Bothrops asper snake venom--synthetic Lys49 myotoxin II-(115–129)- peptide identifies its bactericidal region. Eur J Biochem. 1998;253(2):452–61.
Chacur M, Longo I, Picolo G, Gutiérrez JM, Lomonte B, Guerra JL, et al. Hyperalgesia induced by Asp49 and Lys49 phospholipases A2 from Bothrops asper snake venom: pharmacological mediation and molecular determinants. Toxicon. 2003;41(6):667–78.
Mamede CCN, de Sousa BB, Pereira DFC, Matias MS, de Queiroz MR, de Morais NCG, et al. Comparative analysis of local effects caused by Bothrops alternatus and Bothrops moojeni snake venoms: enzymatic contributions and inflammatory modulations. Toxicon. 2016;117:37–45.
Teixeira CF, Landucci EC, Antunes E, Chacur M, Cury Y. Inflammatory effects of snake venom myotoxic phospholipases A2. Toxicon. 2003;42(8):947–62.
Chioato L, De Oliveira AH, Ruller R, Sá JM, Ward RJ. Distinct sites for myotoxic and membrane-damaging activities in the C-terminal region of a Lys49-phospholipase A2. Biochem J. 2002;366(Pt 3):971–6.
Ruller R, Aragão EA, Chioato L, Ferreira TL, de Oliveira AH, Sà JM, et al. A predominant role for hydrogen bonding in the stability of the homodimer of bothropstoxin-I, a lysine 49-phospholipase A2. Biochimie. 2005;87(11):993–1003.
Laemmli UK. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature. 1970;227(5259):680–5.
Ward RJ, Monesi N, Arni RK, Larson RE, Paço-Larson ML. Sequence of a cDNA encoding bothropstoxin I, a myotoxin from the venom of Bothrops jararacussu. Gene. 1995;156(2):305–6.
Ward RJ, de Oliveira AH, Bortoleto RK, Rosa JC, Faça VM, Greene LJ. Refolding and purification of Bothropstoxin-I, a Lys49-phospholipase A2 homologue, expressed as inclusion bodies in Escherichia coli. Protein Expr Purif. 2001;21(1):134–40.
Nelson RM, Long GL. A general method of site-specific mutagenesis using a modification of the Thermus aquaticus polymerase chain reaction. Anal Biochem. 1989;180(1):147–51.
Zimmermann M. Ethical guidelines for investigations of experimental pain in conscious animals. Pain. 1983;16(2):109–10.
Randallo LO, Selitto JJ. A method for measurement of analgesic activity on inflamed tissue. Arch Int Pharmacodyn Ther. 1957;111(4):409–19.
Zambelli VO, Gross ER, Chen CH, Gutierrez VP, Cury Y, Mochly-Rosen D. Aldehyde dehydrogenase-2 regulates nociception in rodent models of acute inflammatory pain. Sci Transl Med. 2014;6(251):251ra118.
Chaplan SR, Bach FW, Pogrel JW, Chung JM, Yaksh TL. Quantitative assessment of tactile allodynia in the rat paw. J Neurosci Methods. 1994;53(1):55–63.
Milligan ED, Mehmert KK, Hinde JL, Harvey LO, Martin D, Tracey KJ, et al. Thermal hyperalgesia and mechanical allodynia produced by intrathecal administration of the human immunodeficiency virus-1 (HIV-1) envelope glycoprotein, gp120. Brain Res. 2000;861(1):105–16.
Milligan ED, Twining C, Chacur M, Biedenkapp J, O’Connor K, Poole S, et al. Spinal glia and proinflammatory cytokines mediate mirror-image neuropathic pain in rats. J Neurosci. 2003;23(3):1026–40.
Van Arman CG, Nuss GW. Plasma bradykininogen levels in adjuvant arthritis and carrageenan inflammation. J Pathol. 1969;99(3):245–50.
Melaré R, Floriano RS, Gracia M, Rodrigues-Simioni L, da Cruz-Höfling MA, Rocha T. Ultrastructural aspects of mouse nerve-muscle preparation exposed to Bothrops jararacussu and Bothrops bilineatus venoms and their toxins BthTX-I and Bbil-TX: Unknown myotoxic effects. Microsc Res Tech. 2016;79(11):1082–9.
Landucci EC, Castro RC, Pereira MF, Cintra AC, Giglio JR, Marangoni S, et al. Mast cell degranulation induced by two phospholipase A2 homologues: dissociation between enzymatic and biological activities. Eur J Pharmacol. 1998;343(2–3):257–63.
Chioato L, Aragão EA, Lopes Ferreira T, Ivo de Medeiros A. Mapping of the structural determinants of artificial and biological membrane damaging activities of a Lys49 phospholipase A2 by scanning alanine mutagenesis. Biochim Biophys Acta. 2007;176(5):1247–57.
Lomonte B, Angulo Y, Santamaría C. Comparative study of synthetic peptides corresponding to region 115–129 in Lys49 myotoxic phospholipases A2 from snake venoms. Toxicon. 2003;42(3):307–12.
Núñez CE, Angulo Y, Lomonte B. Identification of the myotoxic site of the Lys49 phospholipase A(2) from Agkistrodon piscivorus piscivorus snake venom: synthetic C-terminal peptides from Lys49, but not from Asp49 myotoxins, exert membrane-damaging activities. Toxicon. 2001;39(10):1587–94.
dos Santos JI, Soares AM, Fontes MRM. Comparative structural studies on Lys49-phospholipases A(2) from Bothrops genus reveal their myotoxic site. J Struct Biol. 2009;167(2):106–16.
Lomonte B, Angulo Y, Moreno E. Synthetic peptides derived from the C-terminal region of Lys49 phospholipase A2 homologues from viperidae snake venoms: biomimetic activities and potential applications. Curr Pharm Des. 2010;16(28):3224–30.
Lomonte B, Moreno E, Tarkowski A, Hanson LA, Maccarana M. Neutralizing interaction between heparins and myotoxin II, a lysine 49 phospholipase A2 from Bothrops asper snake venom. Identification of a heparin-binding and cytolytic toxin region by the use of synthetic peptides and molecular modeling. J Biol Chem. 1994;269(47):29867–73.
Calderón L, Lomonte B. Immunochemical characterization and role in toxic activities of region 115–129 of myotoxin II, a Lys49 phospholipase A2 from Bothrops asper snake venom. Arch Biochem Biophys. 1998;358:343–50.
Aragão EA, Chioato L, Ward RJ. Permeabilization of E. coli K12 inner and outer membranes by bothropstoxin-I, A LYS49 phospholipase A2 from Bothrops jararacussu. Toxicon. 2008;51(4):538–46.
Santos-Filho NA, Lorenzon EN, Ramos MA, Santos CT, Piccoli JP, Bauab TM, et al. Synthesis and characterization of an antibacterial and non-toxic dimeric peptide derived from the C-terminal region of Bothropstoxin-I. Toxicon. 2015;103:160–8.
Cintra-Francischinelli M, Caccin P, Chiavegato A, Pizzo P, Carmignoto G, Angulo Y, et al. Bothrops snake myotoxins induce a large efflux of ATP and potassium with spreading of cell damage and pain. Proc Natl Acad Sci. 2010;107(32):14140–5.
Burnstock G. Purines and sensory nerves. Handb Exp Pharmacol. 2009;194:333–92.
Lim RKS. Neuropharmacology of pain and analgesia. Pharmacology of Pain: Proceedings of the First International Pharmacological edited by Lim RKS, Armstrong DEG. PardoPharmacol Pain 9. 2013. p. 169–217.
Verheij HM, Volwerk JJ, Jansen EH, Puyk WC, Dijkstra BW, Drenth J, et al. Methylation of histidine-48 in pancreatic phospholipase A2. Role of histidine and calcium ion in the catalytic mechanism. Biochemistry. 1980;19(4):743–50.
Scott DL, Otwinowski Z, Gelb MH, Sigler PB. Crystal structure of bee-venom phospholipase A2 in a complex with a transition-state analogue. Science. 1990;250(4987):1563–6.
Lomonte B, Rangel J. Snake venom Lys49 myotoxins: From phospholipases A(2) to non-enzymatic membrane disruptors. Toxicon. 2012;60(4):520–30.